Literature DB >> 33803104

Invasive Candida Infections in Neonates after Major Surgery: Current Evidence and New Directions.

Domenico Umberto De Rose1, Alessandra Santisi1, Maria Paola Ronchetti1, Ludovica Martini1, Lisa Serafini2, Pasqua Betta3, Marzia Maino4, Francesco Cavigioli5, Ilaria Cocchi5, Lorenza Pugni6, Elvira Bonanno7, Chryssoula Tzialla8, Mario Giuffrè9, Jenny Bua10, Benedetta Della Torre11, Giovanna Nardella12, Danila Mazzeo13, Paolo Manzoni14, Andrea Dotta1, Pietro Bagolan15, Cinzia Auriti1.   

Abstract

Infections represent a serious health problem in neonates. Invasive Candida infections (ICIs) are still a leading cause of mortality and morbidity in neonatal intensive care units (NICUs). Infants hospitalized in NICUs are at high risk of ICIs, because of several risk factors: broad spectrum antibiotic treatments, central catheters and other invasive devices, fungal colonization, and impaired immune responses. In this review we summarize 19 published studies which provide the prevalence of previous surgery in neonates with invasive Candida infections. We also provide an overview of risk factors for ICIs after major surgery, fungal colonization, and innate defense mechanisms against fungi, as well as the roles of different Candida spp., the epidemiology and costs of ICIs, diagnosis of ICIs, and antifungal prophylaxis and treatment.

Entities:  

Keywords:  antifungal prophylaxis; invasive Candida infections; invasive fungal infections; neonatal surgery; newborns; surgery

Year:  2021        PMID: 33803104      PMCID: PMC7999498          DOI: 10.3390/pathogens10030319

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  102 in total

1.  Diagnostic accuracy of Candida albicans germ tube antibody for invasive candidiasis: systematic review and meta-analysis.

Authors:  Shuzhen Wei; Ting Wu; Ying Wu; Ding Ming; Xiaoli Zhu
Journal:  Diagn Microbiol Infect Dis       Date:  2018-11-06       Impact factor: 2.803

2.  Use of Micafungin for the Prevention and Treatment of Invasive Fungal Infections in Everyday Pediatric Care in France: Results of the MYRIADE Study.

Authors:  Guy Leverger; Jean-François Timsit; Noël Milpied; Bertrand Gachot
Journal:  Pediatr Infect Dis J       Date:  2019-07       Impact factor: 2.129

3.  Microbial epidemiology of candidaemia in neonatal and paediatric intensive care units at the Children's Medical Center, Tehran.

Authors:  Arezu Charsizadeh; Hossein Mirhendi; Bahram Nikmanesh; Hamid Eshaghi; Koichi Makimura
Journal:  Mycoses       Date:  2017-09-22       Impact factor: 4.377

4.  Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns.

Authors:  Gianluca Terrin; Annalisa Passariello; Mario De Curtis; Francesco Manguso; Gennaro Salvia; Laura Lega; Francesco Messina; Roberto Paludetto; Roberto Berni Canani
Journal:  Pediatrics       Date:  2011-12-12       Impact factor: 7.124

Review 5.  "Getting to Zero": preventing invasive Candida infections and eliminating infection-related mortality and morbidity in extremely preterm infants.

Authors:  D A Kaufman
Journal:  Early Hum Dev       Date:  2012-05       Impact factor: 2.079

6.  Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates.

Authors:  E Roilides; E Farmaki; J Evdoridou; J Dotis; E Hatziioannidis; M Tsivitanidou; E Bibashi; I Filioti; D Sofianou; C Gil-Lamaignere; F-M Mueller; G Kremenopoulos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-10       Impact factor: 3.267

7.  Candidemia in pediatric surgery patients.

Authors:  E M Mokaddas; S A Ramadan; S H Abo el Maaty; S C Sanyal
Journal:  J Chemother       Date:  2000-08       Impact factor: 1.714

Review 8.  Role of Echinocandins in Fungal Biofilm-Related Disease: Vascular Catheter-Related Infections, Immunomodulation, and Mucosal Surfaces.

Authors:  Aspasia Katragkou; Emmanuel Roilides; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2015-12-01       Impact factor: 9.079

9.  Effect of fluconazole prophylaxis on Candida fluconazole susceptibility in premature infants.

Authors:  Julie Autmizguine; P Brian Smith; Kristi Prather; Catherine Bendel; Girija Natarajan; Margarita Bidegain; David A Kaufman; David J Burchfield; Ashley S Ross; Paresh Pandit; Wiley A Schell; Jamie Gao; Daniel K Benjamin
Journal:  J Antimicrob Chemother       Date:  2018-12-01       Impact factor: 5.790

10.  Candidemia due to uncommon Candida species in children: new threat and impacts on outcomes.

Authors:  Ming-Horng Tsai; Jen-Fu Hsu; Lan-Yan Yang; Yu-Bin Pan; Mei-Yin Lai; Shih-Ming Chu; Hsuan-Rong Huang; Ming-Chou Chiang; Ren-Huei Fu; Jang-Jih Lu
Journal:  Sci Rep       Date:  2018-10-15       Impact factor: 4.379

View more
  4 in total

1.  Clinical and Microbiological Characteristics of Neonates with Candidemia and Impacts of Therapeutic Strategies on the Outcomes.

Authors:  Yu-Ning Chen; Jen-Fu Hsu; Shih-Ming Chu; Mei-Yin Lai; Chih Lin; Hsuan-Rong Huang; Peng-Hong Yang; Ming-Chou Chiang; Ming-Horng Tsai
Journal:  J Fungi (Basel)       Date:  2022-04-29

2.  Characteristics of Invasive Pulmonary Fungal Diseases Diagnosed by Pathological Examination.

Authors:  Dong Zhang; Xin Li; Junquan Zhang; Junping Wu; Xin Sun
Journal:  Can J Infect Dis Med Microbiol       Date:  2021-10-28       Impact factor: 2.471

3.  Candida albicans: A Major Fungal Pathogen of Humans.

Authors:  Jonathan P Richardson
Journal:  Pathogens       Date:  2022-04-11

4.  Characterization of nanomaterials synthesized from Spirulina platensis extract and their potential antifungal activity.

Authors:  Agnieszka Sidorowicz; Valentina Margarita; Giacomo Fais; Antonella Pantaleo; Alessia Manca; Alessandro Concas; Paola Rappelli; Pier Luigi Fiori; Giacomo Cao
Journal:  PLoS One       Date:  2022-09-16       Impact factor: 3.752

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.